Back to Search Start Over

Non-enzymatic glycoxidation linked with nutrition enhances the tumorigenic capacity of prostate cancer epithelia through AGE mediated activation of RAGE in cancer associated fibroblasts.

Authors :
Krisanits BA
Woods P
Nogueira LM
Woolfork DD
Lloyd CE
Baldwin A
Frye CC
Peterson KD
Cosh SD
Guo QJ
Spruill LS
Lilly MB
Helke K
Li H
Hanna GS
Hamann MT
Thomas C
Ahmed M
Gooz MB
Findlay VJ
Turner DP
Source :
Translational oncology [Transl Oncol] 2022 Mar; Vol. 17, pp. 101350. Date of Electronic Publication: 2022 Jan 25.
Publication Year :
2022

Abstract

The molecular implications of food consumption on cancer etiology are poorly defined. The rate of nutrition associated non-enzymatic glycoxidation, a reaction that occurs between reactive carbonyl groups on linear sugars and nucleophilic amino, lysyl and arginyl groups on fats and proteins, is rapidly increased by food cooking and manufacturing processes. In this study, we assign nutrition-associated glycoxidation with significant oncogenic potential, promoting prostate tumor growth, progression, and metastasis in vivo. Advanced glycation end products (AGEs) are the final irreversible product of non-enzymatic glycoxidation. Exogenous treatment of prostate tumor cells with a single AGE peptide replicated glycoxidation induced tumor growth in vivo. Mechanistically, receptor for AGE (RAGE) deficiency in the stroma inhibited AGE mediated tumor growth. Functionally, AGE treatment induced RAGE dimerization in activated fibroblasts which sustained and increased the migratory potential of tumor epithelial cells. These data identify a novel nutrition associated pathway that can promote a tissue microenvironment conducive for aggressive tumor growth. Targeted and/or interventional strategies aimed at reducing AGE bioavailability as a consequence of nutrition may be viewed as novel chemoprevention initiatives.<br /> (Copyright © 2022. Published by Elsevier Inc.)

Details

Language :
English
ISSN :
1936-5233
Volume :
17
Database :
MEDLINE
Journal :
Translational oncology
Publication Type :
Academic Journal
Accession number :
35091340
Full Text :
https://doi.org/10.1016/j.tranon.2022.101350